Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02720185
Title Window of Opportunity Trial of Dasatinib in Operable Triple Negative Breast Cancers With nEGFR
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison

triple-receptor negative breast cancer



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.